Prevalence of hepatitis A and hepatitis B in the HIV-HCV co-infected population

被引：0
|
作者：
机构：
来源：
Irish Journal of Medical Science | 2001年 / 170卷 / Suppl 2期
关键词：
Mycobacterium Avium; Mycobacterium Avium Complex; Molluscum Contagiosum; Immune Restoration Disease; Progressive Multi;
D O I：
10.1007/BF03169834
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Antiviral Treatment for Hepatitis C Virus in HIV/HCV Co-infected Patients
    Ioannou, George N.
    Scott, John D.
    Yang, Yin
    Green, Pamela
    Beste, Lauren A.
    HEPATOLOGY, 2013, 58 : 225A - 225A
  • [32] Microbial translocation is correlated with HIV evolution in HIV-HCV co-infected patients
    Tudesq, Jean-Jacques
    Dunyach-Remy, Catherine
    Combescure, Christophe
    Doncesco, Regine
    Laureillard, Didier
    Lavigne, Jean-Philippe
    Sotto, Albert
    PLOS ONE, 2017, 12 (09):
  • [33] Recurrence of hepatitis C virus is more severe in liver transplanted HIV-HCV co-infected patients than in HCV mono-infected patients.
    Vallee, JCD
    Feray, C
    Afonso, AMR
    Castaing, D
    Samuel, D
    LIVER TRANSPLANTATION, 2005, 11 (07) : C2 - C2
  • [34] Chronic hepatitis C in HIV-HCV co-infected patients: Liver histology, fibrosis, fibro and immunocompetent cells and in situ detection of HCV.
    Rullier, A
    Trimoulet, P
    Neau, D
    Bernard, PH
    Urbaniak, R
    Winnock, M
    Ballardini, G
    Balabaud, C
    Bioulac-Sage, P
    Le Bail, B
    HEPATOLOGY, 2001, 34 (04) : 437A - 437A
  • [35] Optimizing ribavirin dose in HIV/hepatitis C (HCV) co-infected individuals treated for HCV
    Farley, J.
    Truong, A.
    Horvath, G.
    Nguyen, T.
    Shum, W.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 86 - 87
  • [36] Risks and benefits of antiretroviral therapy in HIV-HCV co-infected patients
    Núñez, M
    Soriano, V
    JOURNAL OF HEPATOLOGY, 2005, 42 (03) : 290 - 292
  • [37] Impact of hepatitis C and liver fibrosis on antiretroviral plasma drug concentrations in HIV-HCV co-infected patients: the HEPADOSE study
    Dominguez, Stephanie
    Ghosn, Jade
    Peytavin, Gilles
    Guiguet, Marguerite
    Tubiana, Roland
    Valantin, Marc Antoine
    Murphy, Robert
    Bricaire, Francois
    Benhamou, Yves
    Katlama, Christine
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (11) : 2445 - 2449
  • [38] PROGRESS IN THE ELIMINATION OF HEPATITIS C VIRUS INFECTION IN HIV-HCV CO-INFECTED PATIENTS IN ISRAEL: A REAL WORLD MULTICENTER STUDY
    Katchman, Helena
    Mor, Orna
    Turner, Dan
    Saadi, Tarek
    Yacoub, Afif
    Shahar, Eduardo
    Goslan, Yael
    Davidov-Derevyanko, Yana
    Shibolet, Oren
    Ben-Ari, Ziv
    Veitsman, Ella
    HEPATOLOGY, 2019, 70 : 964A - 964A
  • [39] Pharmacokinetics of atazanavir in HIV-HCV co-infected patients with or without cirrhosis
    Gatti, F.
    Loregian, A.
    Nasta, P.
    Pagni, S.
    Prestini, K.
    Matti, A.
    Parisi, S. G.
    Biasi, L.
    Puoti, M.
    Boldrin, C.
    Palu, G.
    Carosi, G.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S666 - S666
  • [40] Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV-HCV co-infected patients
    Duclos-Vallée, JC
    Vittecoq, D
    Teicher, E
    Feray, C
    Roque-Afonso, AM
    Lombès, A
    Jardel, C
    Gigou, M
    Dussaix, E
    Sebagh, M
    Guettier, C
    Azoulay, D
    Adam, R
    Ichaï, P
    Saliba, F
    Roche, B
    Castaing, D
    Bismuth, H
    Samuel, D
    JOURNAL OF HEPATOLOGY, 2005, 42 (03) : 341 - 349
12345